Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Prevent an increase in the proportion of nontyphoidal Salmonella infections that are resistant to multiple drug classes — FS‑05 Data

Status: Baseline only

  Baseline only

Most Recent Data:
9.3 percent (2016-18)

Target:
9.3 percent 

Desired Direction:
Maintains

Baseline:
9.3 percent of nontyphoidal Salmonella infections in humans were resistant to 3 or more drug classes in 2016-18 

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Non-typhoidal Salmonella from humans resistant to 3+ classes of antimicrobial agents, 2016-18
(percent)
Maintains

Population 2016-18
Total
9.3
CI 8.7 / 10.0
SE 0.331